Wednesday, 02 July 2025
This website uses cookies. By using our site you agree to our privacy policy
Username:
Password:
Lost username/password
Create an account
  • Home
  • About Us
    • Accreditation
    • Contact Us
  • Newsletters
  • Continuing Education
    • Diffuse Large B-cell Lymphoma
    • Follicular Lymphoma
    • CLL in Rural America
    • Multidisciplinary Perspectives on BTK Inhibitors Adverse Events Management in CLL and MCL

Christian G. Steidl, MD, PhD

Assistant Professor
Department of Pathology and Laboratory Medicine
University of British Columbia
Vancouver, British Columbia
Last modified: November 1, 2021
Authored Items
What is the significance of the tumor microenvironment in classical Hodgkin lymphoma?
Christian G. Steidl, MD, PhD
FAQ published on April 9, 2014
What is the significance of tumor-associated macrophages in classical Hodgkin lymphoma?
Christian G. Steidl, MD, PhD
Clinical Trial Highlights published on March 24, 2014
What is the general role of biomarkers in management of classical Hodgkin lymphoma?
Christian G. Steidl, MD, PhD
FAQ published on February 12, 2014
Prognostic markers from gene expression profiling in formalin-fixed paraffin-embedded tissues
Christian G. Steidl, MD, PhD
9th ISHL Highlights media published on November 4, 2013

MediCom Worldwide, Inc. Links

ManagingAML.com | ManagingMyeloma.com | ManagingMDS.com | ManagingMPN.com | PracticalOncologist.com | PracticalHematologist.com | ManagingCVD.com | ManagingSCD.com | MediComWorldwide.com

©2025 MediCom Worldwide, Inc. All rights reserved

  • Privacy, Terms, and Conditions
  • Contact Us